Smart Cell Patch for DiabetesAccording to the American Diabetes Association, 29.1 million Americans, or 9.3% of the population had diabetes in 2012, and up to 1.4 million people are diagnosed with diabetes every year. Living with this chronic condition can be really difficult for people who need insulin injections to control their blood glucose levels. They have to be always vigilant about blood sugar swings. Now a smart insulin patch offers a simpler, pain-free option to tackle diabetes.

Developed by researchers at the University of North Carolina and North Carolina State University, this unique painless patch can be stuck to the patient’s skin to control diabetes without the need for injections. This is great news for people with Type 1 and Type 2 diabetes who need insulin injections every day to normalize their blood glucose levels.

Insulin, the hormone responsible for regulating levels of glucose in the blood, is produced and secreted by the beta cells in the pancreas. The new synthetic painless patch mimics the function of the beta cells. It is filled with natural beta cells that can detect increase in the blood glucose level and generate the right dose of insulin to control it when needed – without any risk of inducing low blood sugar. This smart patch has a lot of potential to ease diabetes self-care. It has been successfully tested on animals and further studies are planned to prove its efficacy in patients.

Widespread as the condition is, treating diabetes is also a challenge as every patient needs individual care. When it comes to submitting claims, diabetes mellitus coding under ICD-10 requires documentation with greater detail and specificity. In ICD-10, diabetes mellitus (DM) codes are combination codes that require the code description to specify the type of DM (Type I or Type II), the body system affected, and the complication affecting that body system.

Subcategory levels first specify the type of complication by system, such as diabetes with kidney complications, ophthalmic complications, neurological complications, and circulatory complications. The subclassification level then describes the particular manifestation.

The ICD-10 codes to describe the type of diabetes are:

  • E10 – Type 1 diabetes mellitus.
  • E11 – Type 2 diabetes mellitus.

As Type 1 is due to lack of insulin production and Type 2 is due insulin resistance, long-term (current) insulin use has to be recorded separately using code Z79.4.

Examples of indicating type of diabetes associated complications to a very specific degree are:

  • E11.0 – Type 2 diabetes mellitus with hyperosmolarity.
  • E11.00 – Type 2 diabetes without nonketotic hyperglycemic hyperosmolar coma.
  • E11.01 – Type 2 diabetes with coma.

If the patient has diabetes mellitus and chronic kidney disease, the cause and effect of the condition has to be clearly specified for proper medical coding.

  • E11.2 – Type 2 diabetes mellitus with kidney complications.
  • E11.21 – Type 2 with diabetic nephropathy.
  • E11.22 – Type 2 with diabetic chronic kidney disease.
  • E11.29 – Type 2 with other diabetic kidney complication.
  • E11.3 – Type 2 diabetes mellitus with ophthalmic complications.
  • E11.32 – Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy.
  • E11.329 – Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema.

There are many more codes to document diabetes, with greater complexity involved when the patient has multiple complications. The good news is that professional medical coding services are available to ease the task. Experienced coders in reliable medical billing and coding companies will abstract the information from the physicians’ documentation, assign the appropriate codes, and create claims for optimal reimbursement by insurance carriers.